Hepatitis A Infection
From Anvita Health Wiki
Contents |
Etiology
Epidemiology
- accounts for 1/3 of cases of acute viral hepatitis
- fecal-oral transmission
- contaminated food: rasberries, scallions [1]
Clinical-manifestations
- acute, but NOT chronic hepatitis
- children generally have asymptomatic or mild infection
- adults are generally symptomatic & jaundiced
- fever
- fatigue
- nausea, vomiting, diarrhea
- dark urine
- right upper quadrant pain
Laboratory
-
- unexplained acute hepatitis or acute liver failure
- IgM may persist for 4-6 months
- IgG is protective
Complications
- relapsing course of hepatitis
- prolonged cholestasis
- fulminant hepatitis (rare)
- patients with underlying chronic hepatitis B have increased mortality from HAV
Management
- infection is self-limited
- full recovery in 99% of patients
- prophylaxis:
- single dose of HAV vaccine is protective in 90% of patients within 2-4 weeks of inoculation
- booster at 6-12 months
- susceptible persons traveling to endemic area
- 4 weeks prior to departure
- injection drug users
- men who have sex with men
- patients with chronic liver disease
- patients with clotting factor disorders [1]
- immune globulin within 2 weeks of exposure
- adhere to careful handwashing
- avoid work that involves food handling or close personal contact for 2-3 weeks after resolution of disease
- post-exposure, including household contacts
- HAV vaccine works as well as immune serum globulin [4]
More General Terms
Additional Terms
- hepatitis A vaccine (Harvix, VAQTA)
- hepatitis A virus (HAV)
- PCR/southern blot/in-situ hybridization for hepatitis A virus
References
- Medical Knowledge Self Assessment Program (MKSAP) 11, 14, American College of Physicians, Philadelphia 1998, 2006
- Prescriber's Letter 9(7):40 2002
- Advisory Committee on Immunization Practices (ACIP); Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 May 19;55(RR-7):1-23. PMID: [1] Corresponding NGC guideline withdrawn Dec 2011 [2]
- Victor JC et al, Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007, 357:1685 PMID: [3]
- What I need to know about Hepatitis A [4]
- National Guideline Clearinghouse United Kingdom national guideline on the management of the viral hepatitides A, B, and C 2008. (British Association of Sexual Health and HIV) ngc-guideline: [5]
- Hepatitis A virus. New York State Department of Health ngc-guideline: [6]
